Literature DB >> 11958772

Reversibility of structural rearrangements in the negative vesicular membrane upon electrostatic adsorption/desorption of the polycation.

A A Yaroslavov1, A A Efimova, V I Lobyshev, V A Kabanov.   

Abstract

Interaction of small unilamellar vesicles (SUVs), composed of negative diphosphatidylglycerol (cardiolipin, CL(2-)) and neutral dipalmitoylphosphatidylcholine (DPPC), with poly(N-ethyl-4-vinylpyridinium bromide) (PEVP) was studied in water solution above and below the vesicular membrane melting point by means of differential scanning calorimetry, photon correlation spectroscopy, microelectrophoresis, conductometry, and fluorescence techniques. It has been found that CL(2-) species are homogeneously distributed within DPPC-CL(2-) SUV membrane leaflets and between them. Interaction of PEVP with DPPC-CL(2-) SUVs led to drastic structural rearrangements in the membrane if it was in the fluid state (liquid SUVs). Negative CL(2-) molecules migrated from the inner to the outer membrane leaflet and segregated in the vicinity of adsorbed PEVP chains. In addition, PEVP adsorption terminated completely the exchange of lipid molecules between the SUVs. At the same time, the integrity of liquid SUVs contacting PEVP remained unchanged. Since the interaction of PEVP with liquid SUVs was predominantly electrostatic in nature, the polycation could be completely removed from the vesicular membrane by addition of an excess of polyacrylic acid (PAA) polyanions forming a more stable electrostatic complex with PEVP. Removal of PEVP resulted in complete resumption of the original distribution of lipids in lateral and transmembrane directions as well as intervesicular lipid exchange. In contrast, PEVP interacting with DPPC-CL(2-) SUVs formed defects in the vesicular membrane if it was in the gel state (solid SUVs). Such interaction was contributed not only by electrostatic but most likely by hydrophobic interactions involving the defected membrane sites. PEVP kept contacting solid SUVs in the presence of an abundant amount of PAA. The established phenomena may be important for understanding the biological effects of polycations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958772     DOI: 10.1016/s0005-2736(01)00453-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Poly-L-lysine-induced morphology changes in mixed anionic/zwitterionic and neat zwitterionic-supported phospholipid bilayers.

Authors:  Tighe A Spurlin; Andrew A Gewirth
Journal:  Biophys J       Date:  2006-07-28       Impact factor: 4.033

2.  New antibacterial-core structures based on styryl quinolinium.

Authors:  Eunsuk Kim; Seung-Heon Lee; Seung-Jun Lee; O-Pil Kwon; Hyunjin Yoon
Journal:  Food Sci Biotechnol       Date:  2017-04-30       Impact factor: 2.391

Review 3.  Polymer genomics: an insight into pharmacology and toxicology of nanomedicines.

Authors:  Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

4.  Rapid Formation of Peptide/Lipid Coaggregates by the Amyloidogenic Seminal Peptide PAP248-286.

Authors:  Eleanor W Vane; Shushan He; Lutz Maibaum; Abhinav Nath
Journal:  Biophys J       Date:  2020-08-06       Impact factor: 4.033

5.  Biomembrane sensitivity to structural changes in bound polymers.

Authors:  Alexander A Yaroslavov; Tatiana A Sitnikova; Anna A Rakhnyanskaya; Ekaterina G Yaroslavova; Dmitry A Davydov; Tatiana V Burova; Valery Ya Grinberg; Lei Shi; Fredric M Menger
Journal:  J Am Chem Soc       Date:  2009-02-11       Impact factor: 15.419

6.  Cationic/Anionic Polyelectrolyte (PLL/PGA) Coated Vesicular Phospholipid Gels (VPGs) Loaded with Cytarabine for Sustained Release and Anti-glioma Effects.

Authors:  Na Qi; Yu Zhang; Xing Tang; Aimin Li
Journal:  Drug Des Devel Ther       Date:  2020-05-12       Impact factor: 4.162

Review 7.  Antimicrobial polymeric materials with quaternary ammonium and phosphonium salts.

Authors:  Yan Xue; Huining Xiao; Yi Zhang
Journal:  Int J Mol Sci       Date:  2015-02-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.